|
|
Hi Andrew,
I think we made some progress in the following areas:
1. No need to overdo internal disinfection beyond OEM guidelines as risk is minimal.
2. The external surfaces of machines/beds/chairs are where the risks are highest and need to be decontaminated properly.
3. No need for additional external Tx protectors
4. Section 2.5 added - when any machine should be removed from service
5. There is a sustainability and financial cost to disinfecting between every patient. This may be reduced upon agreement of a robust local risk assessment.
I have concerns about the requirements for dedicated beds/chairs for Hep B Delta variant - can't see how this can be managed.
Certainly not perfect but overall a step in the right direction I think.
|
Locked
